Mylan Pharmaceuticals Inc. et al. vs. AstraZeneca AB et al.
Explore the PTAB proceeding IPR2016-01325 filed by Mylan Pharmaceuticals Inc. et al. on 2016-06-29. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2016-01325
Filing Date
2016-06-29
Accorded Filing Date
2016-06-29
Institution Decision Date
2016-12-14
Last Modified Date
2022-10-10
Proceeding Type
IPR
Termination Date
โ
Trial Status
Institution Denied
Parties & Counsel
Petitioner
Mylan Pharmaceuticals Inc. et al.
Represented By
White, Brandonet alPatent Owner / Respondent
AstraZeneca AB et al.
Represented By
Prugo, Filkoet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
2 Total
Proceeding Status
Institution Denied
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (2)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 28165 | Charles Lipsey | +1 571-203-2755 |
| 30413 | John Paul | +1 202-408-4109 |
| 30415 | Richard Racine | +1 202-408-4038 |
| 31744 | Richard Burgujian | +1 571-203-2790 |
| 32120 | Barbara Mccurdy | +1 202-408-4000 X4047 |
| 32409 | Bryan Diner | +1 202-408-4000 |
| 32824 | John Jakes | +1 202-408-4000 |
| 33234 | Michael Flibbert | +1 202-408-4000 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 5 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 8,329,680 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,466,139 B2 | US Continuation / Sibling | View Official Patent → |
| ๐ฌ๐ง United Kingdom | GB 0000313 | United Kingdom Counterpart | View Official Patent → |
| ๐ฌ๐ง United Kingdom | GB 0008837 | United Kingdom Counterpart | View Official Patent → |
| ๐บ๐ธ United States | US 7,456,160 B2 | US Continuation / Sibling | View Official Patent → |
FRESENIUS KABI USA, LLC v. AstraZeneca AB
InnoPharma Licensing LLC et al. v. AstraZeneca AB
InnoPharma Licensing LLC et al. v. AstraZeneca AB
Mylan Pharmaceuticals Inc. v. AstraZeneca AB
Mylan Pharmaceuticals Inc. v. AstraZeneca AB
AstraZeneca Pharmaceuticals LP v. Fresenius Kabi USA, LLC
AstraZeneca Pharmaceuticals LP v. Mylan Institutional LLC
ASTRAZENECA PHARMACEUTICALS LP v. SAGENT PHARMACEUTICALS, INC.
AstraZeneca Pharmaceuticals LP v. Teva Parenteral Medicines Inc.